Clinical Trial Failure

Max Former Hodgkins Stage 3
Max Former Hodgkins Stage 3 CSN Member Posts: 3,830 Member
in Lymphoma (Hodgkin and Non-Hodgkin) #1

I don't think anyone at the Board has mentioned bieng part of this, but it is important to be aware of, especially members with T-cell issues. 

max

http://www.foxnews.com/health/2016/07/08/juno-cancer-study-halted-after-patient-deaths.html

 

.

 

.

Comments

  • po18guy
    po18guy CSN Member Posts: 1,539 Member
    edited July 2016 #2
    Strange demographic - 20

    Strange demographic - 20 somethings, and a strange dynamic in the unpredicted and undesireable side effect. I had fludarabine and Cyclophosphamide as conditioning for my transplant (it is SOP at Fred Hutch) and nearly everyone I know maintains that I survived it. This is a huge blow to the trial, but the data, morbid as it is, will certainly help to guide future trials. However, going to a less effective conditioning regimen seems only to guarantee worse overall results. A true catch-22 and sadly, part and parcel of research.  

Discussion Boards